FFWA
CLLS

FRG Family Wealth Advisors’s Cellectis CLLS Stock Holding History

FRG Family Wealth Advisors’s Portfolio CLLS Stock Details CLLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-80
Closed -$205 – 180
2024
Q1 		$205 Buy
+80
New +$221 ﹤0.01% 361

Other funds holding CLLS

LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $39.9B AUM 29.7% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

FRG Family Wealth Advisors's CLLS Position: Q2 2024 in Review

FRG Family Wealth Advisors sold out of Cellectis (CLLS) in Q2 2024, closing a stake of 80 shares — an estimated $205 sold.

FRG Family Wealth Advisors first reported a position in CLLS in Q1 2024 and held it in 1 quarter. The position peaked at $205 in Q1 2024. 27 funds tracked by Wall St. Rank hold CLLS as of Q2 2024.

  • FRG Family Wealth Advisors reported no remaining Cellectis position as of Q2 2024 after selling out during the quarter.
  • FRG Family Wealth Advisors sold 80 Cellectis shares in Q2 2024, an estimated $205.
  • FRG Family Wealth Advisors first reported a position in Cellectis in Q1 2024 and held it in 1 quarter.
  • FRG Family Wealth Advisors's Cellectis position peaked at $205 in Q1 2024.
  • 27 funds tracked by Wall St. Rank held Cellectis as of Q2 2024.

Based on FRG Family Wealth Advisors's 13F filing for Q2 2024, filed 7 Aug 2024.